Karyopharm Therapeutics Inc. (KPTI)
NASDAQ: KPTI · Real-Time Price · USD
4.450
+0.430 (10.70%)
At close: Aug 13, 2025, 4:00 PM
4.450
0.00 (0.00%)
Pre-market: Aug 14, 2025, 8:49 AM EDT
Karyopharm Therapeutics Employees
Karyopharm Therapeutics had 279 employees as of December 31, 2024. The number of employees decreased by 46 or -14.15% compared to the previous year.
Employees
279
Change (1Y)
-46
Growth (1Y)
-14.15%
Revenue / Employee
$492,004
Profits / Employee
-$442,889
Market Cap
38.59M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
KPTI News
- 2 days ago - Karyopharm Therapeutics Inc. (KPTI) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 days ago - Karyopharm Reports Second Quarter 2025 Financial Results and Highlights Recent Company Progress - PRNewsWire
- 9 days ago - Karyopharm to Report Second Quarter 2025 Financial Results on August 11, 2025 - PRNewsWire
- 12 days ago - Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PRNewsWire
- 2 months ago - Karyopharm to Present at the Jefferies Global Healthcare Conference - PRNewsWire
- 3 months ago - Karyopharm to Participate at the 2025 RBC Capital Markets Global Healthcare Conference - PRNewsWire
- 3 months ago - Karyopharm Announces Poster Presentation on Selinexor in Myelofibrosis at the 2025 European Hematology Association Annual Meeting - PRNewsWire
- 3 months ago - These Analysts Revise Their Forecasts On Karyopharm Therapeutics After Q1 Results - Benzinga